In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea

被引：39

作者：

Sierra, JM ^{[1
]}

Ruiz, J ^{[1
]}

Navia, MM ^{[1
]}

Vargas, M ^{[1
]}

Gascon, J ^{[1
]}

Vila, J ^{[1
]}

机构：

[1] Univ Barcelona, Sch Med, Hosp Clin, IDIBAPS,Inst clin Infecc & Immunol, E-08036 Barcelona, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 02期

关键词：

D O I：

10.1128/AAC.45.2.643-644.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：643 / 644

页数：2

共 13 条

[1] Tropical and exotic infections [J].

Beeching, NJ ;

Hart, CA ;

Duerden, BI .

JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (01) :5-27

[2] Rifaximin: A nonabsorbed antimicrobial in the therapy of travelers' diarrhea [J].

DuPont, HL ;

Ericsson, CD ;

Mathewson, JJ ;

Palazzini, E ;

DuPont, MW ;

Jiang, ZD ;

Mosavi, A ;

de la Cabada, FJ .

DIGESTION, 1998, 59 (06) :708-714

[3]

DUPONT HL, 1999, 39 INT C ANT AG CHEM, P698

[4]

Gallardo F, 1998, J Travel Med, V5, P23, DOI 10.1111/j.1708-8305.1998.tb00451.x

[5] ETIOLOGY OF TRAVELERS DIARRHEA IN SPANISH TRAVELERS TO DEVELOPING-COUNTRIES [J].

GASCON, J ;

VILA, J ;

VALLS, ME ;

RUIZ, L ;

VIDAL, J ;

CORACHAN, M ;

PRATS, G ;

DEANTA, MTJ .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (02) :217-223

[6] RIFAXIMIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN CONDITIONS MEDIATED BY GASTROINTESTINAL BACTERIA [J].

GILLIS, JC ;

BROGDEN, RN .

DRUGS, 1995, 49 (03) :467-484

[7] ANTIMICROBIAL ACTIVITY AND SPECTRUM OF RIFAXIMIN, A NEW TOPICAL RIFAMYCIN DERIVATIVE [J].

HOOVER, WW ;

GERLACH, EH ;

HOBAN, DJ ;

ELIOPOULOS, GM ;

PFALLER, MA ;

JONES, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 16 (02) :111-118

[8] In vitro activity and fecal concentration of rifaximin after oral administration [J].

Jiang, ZD ;

Ke, S ;

Palazzini, E ;

Riopel, L ;

Dupont, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2205-2206

[9]

*NAT COMM CLIN LAB, 1997, M7A4 NAT COMM CLIN L

[10]

RIPA S, 1987, DRUG EXP CLIN RES, V13, P483

← 1 2 →